The multilayered transcriptional architecture of glioblastoma ecosystems
Top Cited Papers
Open Access
- 9 May 2025
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 57 (5) , 1155-1167
Abstract
In isocitrate dehydrogenase wildtype glioblastoma (GBM), cellular heterogeneity across and within tumors may drive therapeutic resistance. Here we analyzed 121 primary and recurrent GBM samples from 59 patients using single-nucleus RNA sequencing and bulk tumor DNA sequencing to characterize GBM transcriptional heterogeneity. First, GBMs can be classified by their broad cellular composition, encompassing malignant and nonmalignant cell types. Second, in each cell type we describe the diversity of cellular states and their pathway activation, particularly an expanded set of malignant cell states, including glial progenitor cell-like, neuronal-like and cilia-like. Third, the remaining variation between GBMs highlights three baseline gene expression programs. These three layers of heterogeneity are interrelated and partially associated with specific genetic aberrations, thereby defining three stereotypic GBM ecosystems. This work provides an unparalleled view of the multilayered transcriptional architecture of GBM. How this architecture evolves during disease progression is addressed in the companion manuscript by Spitzer et al.Keywords
This publication has 53 references indexed in Scilit:
- Purification and characterization of human neural stem and progenitor cellsCell, 2023
- Glioblastoma hijacks neuronal mechanisms for brain invasionCell, 2022
- Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastomaCancer Cell, 2022
- Glioma progression is shaped by genetic evolution and microenvironment interactionsCell, 2022
- Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastomaCancer Cell, 2021
- Integrated analysis of multimodal single-cell dataCell, 2021
- An Integrative Model of Cellular States, Plasticity, and Genetics for GlioblastomaCell, 2019
- Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the MicroenvironmentCancer Cell, 2017
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse GliomaCell, 2016
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010